Lipididentifizierung in der LC-MS-basierten Lipidomik mittels einer Kombination aus SWATH und DMS

Similar documents
Lipidomic Analysis by UPLC-QTOF MS

SelexION Technology for Lipid Analysis: Pushing the Boundaries of Lipidomics

Automated Lipid Identification Using UPLC/HDMS E in Combination with SimLipid

Moving from targeted towards non-targeted approaches

Non targeted Lipidomic Analysis by Direct Infusion Mass Spectrometry. Jianzhong Chen, PhD Assistant Professor School of Optometry UAB

Phospholipid characterization by a TQ-MS data based identification scheme

Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis

Supporting Information

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

LC/MS Method for Comprehensive Analysis of Plasma Lipids

INTRODUCTION CH 3 CH CH 3 3. C 37 H 48 N 6 O 5 S 2, molecular weight Figure 1. The Xevo QTof MS System.

Obtaining Answers to Biological Questions Sample Prep to Data Analysis. Jeremiah D. Tipton, Ph.D. SCIEX Advanced Workflow Specialist in OMICS

Impact of Chromatography on Lipid Profiling of Liver Tissue Extracts

Targeted and untargeted metabolic profiling by incorporating scanning FAIMS into LC-MS. Kayleigh Arthur

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Increasing the Peak Capacity of LC/MS/MS Systems for the Analysis of Complex Biological Samples

Improving Coverage of the Plasma Lipidome Using Iterative MS/MS Data Acquisition Combined with Lipid Annotator Software and 6546 LC/Q-TOF

Fast Separation of Triacylglycerols in Oils using UltraPerformance Convergence Chromatography (UPC 2 )

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Mass Spectrometry based metabolomics

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

MS/MS Library Creation of Q-TOF LC/MS Data for MassHunter PCDL Manager

MASS SPECTROMETRY BASED METABOLOMICS. Pavel Aronov. ABRF2010 Metabolomics Research Group March 21, 2010

LC-Based Lipidomics Analysis on QTRAP Instruments

Impurity Identification using a Quadrupole - Time of Flight Mass Spectrometer QTOF

New Developments in LC-IMS-MS Proteomic Measurements and Informatic Analyses

Metabolomic and Lipidomic Research in Diabetes and Obesity 08/07/2013

NON TARGETED SEARCHING FOR FOOD

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Metabolite identification in metabolomics: Metlin Database and interpretation of MSMS spectra

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Lipids Analysis. Lipids

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

How to Use TOF and Q-TOF Mass Spectrometers

PTM Discovery Method for Automated Identification and Sequencing of Phosphopeptides Using the Q TRAP LC/MS/MS System

Profiling Flavonoid Isomers in Highly Complex Citrus Juice Samples Using UPLC Ion Mobility Time-of-Flight Mass Spectrometry

The use of mass spectrometry in lipidomics. Outlines

Discovery Metabolomics - Quantitative Profiling of the Metabolome using TripleTOF Technology

Metabolite identification in metabolomics: Database and interpretation of MSMS spectra

4-Fluoroethamphetamine

Identification of Ginsenosides Using the SCIEX X500R QTOF System

Amadeo R. Fernández-Alba

application Natural Food Colorants Analysis of Natural Food Colorants by Electrospray and Atmospheric Pressure Chemical Ionization LC/MS

Mass-Spectrometric Analysis of Lipids (Lipidomics)

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Metabolomic fingerprinting of serum samples by direct infusion mass spectrometry

for the Identification of Phosphorylated Peptides

Chemical Analysis Business Operations Waters Corporation Milford MA

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Shotgun Proteomics MS/MS. Protein Mixture. proteolysis. Peptide Mixture. Time. Abundance. Abundance. m/z. Abundance. m/z 2. Abundance.

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Data Independent MALDI Imaging HDMS E for Visualization and Identification of Lipids Directly from a Single Tissue Section

Latest Innovations in LC/MS/MS from Waters for Metabolism and Bioanalytical Applications

High Resolution Glycopeptide Mapping of EPO Using an Agilent AdvanceBio Peptide Mapping Column

AB Sciex QStar XL. AIMS Instrumentation & Sample Report Documentation. chemistry

SUPPORTING INFORMATION:

Accumulation and transformation of inorganic and organic arsenic in rice and role of

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

ION MOBILITY COUPLED TO HIGH RESOLUTION MASS SPECTROMETRY: THE POSSIBILITIES, THE LIMITATIONS

Increased Identification Coverage and Throughput for Complex Lipidomes

Lipid Class Separation Using UPC 2 /MS

Rapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

MALDI Imaging Drug Imaging Detlev Suckau Head of R&D MALDI Bruker Daltonik GmbH. December 19,

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

Identification & Confirmation of Structurally Related Degradation Products of Simvastatin

Quantitation of Sphingolipids in Tissue Extracts by LC/MS/MS

High resolution mass spectrometry for bioanalysis at Janssen. Current experiences and future perspectives

Choosing the metabolomics platform

Don t miss a thing on your peptide mapping journey How to get full coverage peptide maps using high resolution accurate mass spectrometry

Sue D Antonio Application Chemist Cedar Creek, TX

Supporting information

Supplementary Information

A UPLC/MS Approach for the Diagnosis of Inborn Errors of Metabolism

Simple Method (IS-MRM) to Monitor Lysophospholipids and Phospholipids During LC-MS Method Development via In-Source CID

PosterREPRINT RAPID, SELECTIVE SCREENING OF URINE SAMPLES FOR GLUCURONIDES BY LC/MS/MS INTRODUCTION ABSTRACT

Agilent 6470 Triple Quadrupole LC/MS System and EMR-Lipid. The Combination for Confident Pesticide Quantitation. Christoph Mueller

[application note] DIRECT TISSUE IMAGING AND CHARACTERIZATION OF PHOSPHOLIPIDS USING A MALDI SYNAPT HDMS SYSTEM

Relative Quantitation of Human Polymorphonuclear Leukocyte Cell Membrane GPEtn Lipids

Determination of Chlorophenoxyacetic Acid and Other Acidic Herbicides Using a QuEChERS Sample Preparation Approach and LC-MS/MS Analysis

Using Software Tools to Improve the Detection of Impurities by LC/MS. Application Note. Christine Miller Agilent Technologies.

LC-MS. Pre-processing (xcms) W4M Core Team. 29/05/2017 v 1.0.0

Direct Analysis of Folic Acid in Digestive Juices by LC/TOF-MS Application

Identification of Imidacloprid Metabolites in Onions Using High Resolution Accurate Mass Spectrometry (LC/Q-TOF MS) and Accurate Mass Tools

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

ANALYTICAL REPORT 1 3C-P (C14H23NO3) 1-(3,5-dimethoxy-4-propoxylphenyl)propan-2-amine.

Sunil Kulkarni Product Specialist Agilent Technologies

Analysis of several common. organic acids in tobacco leaf, snus, and moist snuff

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Profiling of Endogenous Metabolites Using Time-of-Flight LC/MS with Ion Pair Reverse Phase Chromatography

Advancing your Forensic Toxicology Analyses; Adopting the Latest in Mass Spectrometry Innovations

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

International Journal of Applied Pharmaceutical Sciences and Research

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Metabolomic and Proteomics Solutions for Integrated Biology. Christine Miller Omics Market Manager ASMS 2015

QSTAR Operation. May 3, Bob Seward

SEPARATION OF BRANCHED PFOS ISOMERS BY UPLC WITH MS/MS DETECTION

A Metabolomics Approach to Profile Novel Chemical Markers for Identification and Authentification of Terminalia Species

ANALYTICAL REPORT 1 DPT (C16H24N2) [2-(1H-indol-3-yl)ethyl]dipropylamine.

Transcription:

Lipididentifizierung in der LC-MS-basierten Lipidomik mittels einer Kombination aus SWATH und DMS Michael Witting, et al. Helmholtz Zentrum München Research Unit Analytical BioGeoChemistry Berlin, 14/3/17

Lipid identification in LC-MS based lipidomics using a combination of SWATH and DMS Michael Witting, et al. Helmholtz Zentrum München Research Unit Analytical BioGeoChemistry Berlin, 14/3/17

Motivation Complexity of the C. elegans lipidome Witting, M, et al. The C. elegans lipidome. Arch Biochem Biophys. 215 Jun 1. pii: S3-9861(15)267-2

Motivation Complexity of the C. elegans lipidome

Motivation Complexity of the C. elegans lipidome and ways to tackle it Witting, M, et al. The C. elegans lipidome. Arch Biochem Biophys. 215 Jun 1. pii: S3-9861(15)267-2

Motivation Complexity of the C. elegans lipidome and ways to tackle it Witting, M, et al. The C. elegans lipidome. Arch Biochem Biophys. 215 Jun 1. pii: S3-9861(15)267-2

Lipid identification strategies DDA, DIA and DIA-SWATH DDA DIA DIA-SWATH + - Precursor known - No reconstruction of spectra required - - Coverage problem - Precursor unknown - Reconstruction of spectra required - Large overlap of signals - No coverage problem - Precursor range known - No coverage problem - Exact Precursor mass unknown - Reconstruction of spectra required - Partial overlap of signals - Overlap in DIA causes merged spectra - Merged spectra reduce MS/MS scoring Analysis of single lipid classes in one run Use DMS to clean spectra on the fly Witting, M, et al., LipidFrag: Improving reliability of in silico fragmentation of lipids and application to the Caenorhabditis elegans lipidome, http://dx.doi.org/1.1371/journal.pone.172311,

Experimental setup LC conditions UPLC Instrument: Agilent 129 Column: Waters Acquity UPLC HSS T3 Column, 1Å, 1.8 μm, 2.1 mm X 1 mm Mobile phase A: 6:4 Water:ACN with 1 mm NH 4 HCO 2 and.1% formic acid Mobile phase B: 9:1 IPA:ACN with 1 mm NH 4 HCO 2 and.1% formic acid Column Temperature: 5 C Flow rate: 4 ul/min

Experimental setup LC conditions TOF Selexion Parameter Value Parameter Value Accumulation Time 1. ms Separation Voltage 4 Curtain Gas 25 Compensation Voltage Varies Gas 1 3 DMS offset -3 Gas 2 5 Ionization Voltage 55 Declustering Potential 8 Source Temperature 6 Start Mass 3 End Mass 1 Resolution enhancement DMS Temperature Modifier Modifier Composition Low Low 1-Propanol Low

Development of XCMS workflow Building a SWATH support for XCMS Acquisition with SWATH (one run per COV) Conversion to.ml XCMS for processing (workflow for SWATH required)

Development of XCMS workflow Building a SWATH support for XCMS first tests Split data into MS1 and MS2 data Sort MS2 data into different SWATH pockets Perform peak picking on each in individual Select MS1 precursor and search for respective SWATH pocket Find fitting peaks based on RT Get EICs for Precursor and each fragment ion in RT region of precursor Perform correlation analysis Data file MS1 MS2 MS2 MS2 MS1 MS2 MS2 MS2 intensity 2 15 1 5 1..75 497.5 5. 52.5 55. rt massdiff -2-4 -6 15 1 2 4 6 8 cor.5.25 5. 2 4 6 8 2 4 6 8

Development of XCMS workflow Spectra reconstruction: TG(12:/12:/12:) (m/z 656.59) 3e+5 Fatty Acyl Substituent Neutral Loss (NL) RCOOH + NH 3 2e+5-2 12: 217 intensity massdiff 14: 245 15: 259 1e+5-4 16:1 271 16: 273 17:1 285 e+ -6 17: 287 47 48 49 rt 2 4 6 18:3 295 6e+6 18:2 297.95 18:1 299 18: 31.9 4e+6 19: 315 2:5 319 cor.85 2e+6 2:4 321 2:2 325 2:1 327.8 2: 329 22:6 345.75 e+ 2 4 6 2 4 6

Development of XCMS workflow Spectra reconstruction: TG(18:1/18:1/16:) (m/z 876.8) 6 Fatty Acyl Substituent Neutral Loss (NL) RCOOH + NH 3 4-1 12: 217 intensity massdiff 14: 245 15: 259 2-2 16:1 271 16: 273-3 17:1 285 17: 287 56 58 6 rt 6 7 8 9 18:3 295 1. 4e+5 18:2 297 18:1 299.9 18: 31 3e+5 19: 315.8 2:5 319 cor 2e+5 2:4 321.7 2:2 325 1e+5 2:1 327.6 2: 329 22:6 345 e+ 6 7 8 9 6 7 8 9

Development of Workflow with standards TIC of all standards

Development of Workflow with standards PC samples fragment m/z 184.7

Development of Workflow with standards PC samples fragment m/z 184.7.8 V 1.6 V 2.4 V 3.2 V 4. V 4.8 V

Development of Workflow with standards C. elegans samples fragment m/z 184.7

Development of Workflow with standards C. elegans samples fragment m/z 184.7.2 V 1. V 1.8 V 2.6 V 3.4 V 4.2 V

What can DMS now add? PC standards 4e+6 3e+6 2 sample PC_SWATH_pos_DMS15-PC variable PC_SWATH_pos_DMS16-PC value 2e+6 PC.36.5. PC.36.4. PC.36.3. intensity PC_SWATH_pos_DMS17-PC PC_SWATH_pos_DMS18-PC PC_SWATH_pos_DMS19-PC PC.36.2. 1 PC_SWATH_pos_DMS2-PC PC_SWATH_pos_DMS21-PC 1e+6 PC_SWATH_pos_DMS22-PC e+ -1 1 2 3 4 5 Cov 3 325 35 375 4 rt

What can DMS no add? C. elegans samples PC(36:6) 1 3 Area 75 5 25 intensity 2 1 sample Pos_LC-DMS-SWATH16 Pos_LC-DMS-SWATH17 Pos_LC-DMS-SWATH18 Pos_LC-DMS-SWATH2 Pos_LC-DMS-SWATH21 Pos_LC-DMS-SWATH22 Pos_LC-DMS-SWATH23 Pos_LC-DMS-SWATH24 Pos_LC-DMS-SWATH26 Pos_LC-DMS-SWATH27-2 2 4 Cov 2 225 25 275 3 rt

What can DMS no add? C. elegans samples PC(36:6) 3-1 intensity 2 massdiff -2-3 1-4 -5 1. 25 21 215 22 rt 8e+5 73 74 75 76 77 78 6e+5.8 cor 4e+5.6 2e+5.4 e+ 73 74 75 76 77 78 73 74 75 76 77 78

What can DMS no add? C. elegans samples TG(55:6) Fatty Acyl Substituent Neutral Loss (NL) RCOOH + NH 3 4-1 12: 217 14: 245 intensity 2 massdiff -2 15: 259 16:1 271 16: 273-3 17:1 285 17: 287 49. 492.5 495. 497.5 rt 6 7 8 9 18:3 295 1. 18:2 297 15 18:1 299.8 18: 31 1 19: 315 cor.6 5 2:5 319 2:4 321 2:2 325.4 2:1 327 6 7 8 9 6 7 8 9 2: 329 22:6 345

Acknowledgment AB Sciex Cyrus Papan Bernd Müller TU München Andreas Dunkel IPB Halle Steffen Neumann BGC, especially Philippe Schmitt-Kopplin

Acknowledgment Funding sources